Still Her

Health & Wellness Through Menopause

Free: What's your menopause season? Take the 60-second quiz →

Journal The Still Her Series · Part 4

Hormones & Intimacy

HRT, Revisited

What changed since the headlines that scared a generation off it.

Article 23 of 30 · 7 min read

In the summer of 2002, the evening news led with a frightening headline: hormone therapy might cause cancer. Millions of women heard it. Many called their mothers, sisters and friends, and a lot of them stopped their hormones that same week.

Twenty years later, many of their daughters are in menopause themselves. And when the hot flashes and 3 a.m. wake-ups start, a lot of them don't even bring up hormone therapy with their doctor. In their heads, it's still "the thing that causes cancer." So they white-knuckle it, sometimes for years.

It turns out a lot of what we all "knew" about hormone therapy came from one study, misunderstood headlines, and a warning label that the FDA itself has now started taking off. So let's take a fresh, honest look.

The 2002 scare: what the study found, and what got lost

The Women's Health Initiative (WHI) was a huge government study of hormone therapy. In July 2002, part of it was stopped early after researchers saw higher rates of breast cancer, heart disease, stroke and blood clots in women taking a combined estrogen and progestin pill compared with placebo.

The news coverage was terrifying, and prescriptions dropped by about half within months. In 2003, the FDA put its most serious "boxed" warning on hormone therapy products.

Here's what got lost in the panic:

  • The women were older than most women who start hormones. Their average age was 63, often a decade or more past menopause. That turns out to matter a lot.
  • It tested one older formula (horse-derived estrogen plus a synthetic progestin) that's much less commonly prescribed today.
  • The headlines used scary relative numbers. The breast cancer finding was reported as a 26% increase. In real terms, that was about 8 extra cases per 10,000 women per year, and even that result was borderline in the original data.
  • The estrogen-only part of the study looked different. In women without a uterus who took estrogen alone, breast cancer rates were actually lower than with placebo, and that lower risk lasted in long-term follow-up.

None of this means the risks were made up. It means they were real for certain women, and got applied to everyone.

What we know now: timing matters

Illustration of a calendar and a clock

When researchers went back and looked at the WHI and other studies by age, a clear pattern showed up. Researchers call it the "timing hypothesis": hormone therapy seems to work very differently depending on when you start it.

The Menopause Society (formerly the North American Menopause Society) reviewed all of this in its 2022 position statement. Its key conclusions:

  • It's the most effective treatment for hot flashes and night sweats, and for vaginal dryness and painful sex (often called genitourinary syndrome of menopause).
  • It helps prevent bone loss and fractures.
  • For healthy women under 60, or within 10 years of menopause, the benefits outweigh the risks for treating bothersome symptoms and preventing bone loss.
  • Starting later changes the math. For women who start more than 10 years after menopause or after 60, the risks of heart disease, stroke, blood clots and dementia are higher, so the balance is less favorable.
  • How you take it matters. Patches, gels and sprays through the skin, and lower doses, may carry a lower risk of blood clots and stroke than pills.
  • There's no automatic cutoff. Women don't have to stop just because they turn 60 or 65 if it's still helping and they've talked it through with their doctor.

What about breast cancer? The risk depends on the type. For combined estrogen and progestogen, the risk doesn't seem to rise much with short-term use, but may go up slightly with longer use. For estrogen alone, the risk may actually be lower. If breast cancer runs in your family, this is an important conversation to have with your doctor.

The FDA label change, and where things stand now

This is the big news. In November 2025, the FDA announced it would remove the boxed warning about heart disease, breast cancer and probable dementia from hormone therapy products. It called the old warnings outdated, after a review of the research, an expert panel and a public comment period.

Since then:

  • In February 2026, the FDA approved new labels for the first six products, including combined pills, estrogen-only pills, progesterone and vaginal estrogen.
  • In October 2026, it updated three more, with more labels on the way.
  • The new labels advise women and doctors to weigh age, health history and timing, and they drop the old "lowest dose for the shortest time" rule.

One warning stays. Estrogen taken alone can thicken the lining of the uterus and raise the risk of uterine cancer. That's why women who still have a uterus are prescribed a progestogen along with estrogen.

The FDA also pointed out how few women are being treated. In 2020, about 41 million American women were 45 to 64, but only about 2 million got a hormone therapy prescription.

Not every expert loves how fast things have swung, and some worry women will now hear that hormones are risk-free. They aren't. But the old warning scared off a lot of women who could have been helped, and that's changing.

Types of hormone therapy, in plain words

Illustration of a pill pack, a tube of gel and capsules
  • Estrogen alone. For women who no longer have a uterus.
  • Estrogen plus a progestogen. For women who still have a uterus, to protect its lining. The progestogen can be micronized progesterone (a "body-identical" form) or a synthetic progestin.
  • Systemic vs. local. Systemic hormones (pills, patches, gels, sprays, rings) travel through your whole body and treat hot flashes, sleep and bone loss. Low-dose vaginal estrogen (creams, tablets, rings) mostly stays local and treats dryness, painful sex and frequent urinary infections. (See Vaginal Dryness: The Symptom Nobody Mentions and Another UTI?)
  • FDA-approved vs. compounded. "Bioidentical" hormones come in FDA-approved versions, too. Custom-compounded hormones from specialty pharmacies aren't FDA-approved, and the Menopause Society has raised concerns about inconsistent doses, purity and missing safety information.

There are also non-hormone prescription options for hot flashes if hormones aren't right for you. Your doctor can walk you through them.

Who it may not be right for

Removing the boxed warning doesn't mean hormone therapy is right for everyone. Systemic hormone therapy usually isn't recommended if you have, or have had:

  • Breast cancer, or another cancer that's sensitive to estrogen
  • Blood clots in your legs or lungs
  • A stroke or heart attack
  • Active liver disease
  • Vaginal bleeding that hasn't been explained
  • Or if you could be pregnant

If you're more than 10 years past menopause or over 60 and just starting out, it's still worth a conversation, but your doctor will weigh the risks more carefully. And if hormones aren't an option for you, there are non-hormone treatments worth asking about.

Questions to bring to your doctor

Illustration of a thoughtful woman next to a checklist

If your doctor brushes this off, or still talks about hormone therapy the way everyone did in 2002, it's okay to see someone else. The Menopause Society has a directory of menopause specialists you can search, and Your Doctor Shrugged? walks you through finding one. Here's what to ask:

  • Based on my age, health and family history, am I a good candidate for hormone therapy?
  • Which type would you suggest for me, and why? Pill, patch, gel or vaginal?
  • Do I need a progestogen? Which kind?
  • What are my personal risks, especially for breast cancer, blood clots and stroke?
  • How will we know if it's working, and when should we check in?
  • If hormones aren't right for me, what non-hormone options do I have?
  • How does it fit with my other medications, including a GLP-1 if I'm on one?

The bottom line

For two decades, a lot of women were scared away from hormone therapy because of one study in older women, one older formula, and headlines that made the risks sound bigger than they were. The research and now the FDA's own labels have caught up.

Hormone therapy isn't risk-free, and it isn't for everyone. But for many healthy women under 60 or within 10 years of menopause, it's the most effective treatment we have for hot flashes, sleep problems and vaginal symptoms, and it protects your bones. You deserve to have a real conversation about it, based on today's science, not 2002's headlines.

Asking can take as little as twenty minutes with your doctor, going through your history and options. Don't wait years to have that conversation.

What's next in this series

Next up: Is Your Collagen Powder a Waste of Money? What the Trials Really Show. We'll look at whether collagen supplements actually do anything for your skin, joints and bones, or whether it's just expensive powder.

Not sure where you are in all of this? Take our quiz: What's your menopause season? It takes two minutes and points you to the articles that fit where you are right now.

Sources

  • The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 2022. Link
  • Pharmacy Times. FDA removes black boxed warning from hormone therapies for menopause, November 2025. Link
  • Becker's Hospital Review. FDA to remove boxed warnings from hormone therapy for menopause, November 2025. Link
  • Patient Care. FDA removes boxed warnings from select menopausal hormone therapy labels, February 2026. Link
  • Contemporary OB/GYN. FDA removes boxed warnings from 3 more menopausal hormone therapy products, October 30, 2026. Link
  • Elimination of the black box warning on menopausal hormone therapy. Obstetrics & Gynecology, 2026. Link
  • American Family Physician. Long-term follow-up after the Women's Health Initiative estrogen-only trial, 2012. Link

This article is for education only and isn't medical advice. Hormone therapy is a prescription treatment with real risks and benefits. Talk with your own doctor about whether it's right for you.

New articles, by email

Never miss a new article.

Pop your email in below and we'll send you every new article as soon as it's published. No spam, and you can unsubscribe anytime.

You're in. We'll email you as soon as the next article goes live.